Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer disease

Sergey Shcherbinin, Adam J. Schwarz, Abhinay Joshi, Michael Navitsky, Matthew Flitter, William R. Shankle, Michael D. Devous, Mark A. Mintun

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

We report kinetic modeling results of dynamic acquisition data from 0 to 100 min after injection with the tau PET tracer 18F-AV-1451 in 19 subjects. Methods: Subjects were clinically diagnosed as 4 young cognitively normal, 5 old cognitively normal, 5 mild cognitive impairment, and 5 Alzheimer disease (AD). Kinetic modeling was performed using Logan graphical analysis with the cerebellum crus as a reference region. Voxelwise binding potential (BP) and SUV ratio (SUVR80-100) images were compared. Results: In AD subjects, slower and spatially nonuniform clearance from cortical regions was observed as compared with the controls, which led to focal uptake and elevated retention in the imaging data from 80 to 100 min after injection. BP from the dynamic data from 0 to 100 min correlated strongly (R2 > 0.86) with corresponding regional SUVR80-100-1 values. In the putamen, the observed kinetics (positive SUVR1-5-1 at the tracer delivery stage and plateauing time - SUVR curves for all diagnostic categories) may suggest either additional off-target binding or a second binding site with different kinetics. Conclusion: The kinetics of the 18F-AV-1451 tracer in cortical areas, as examined in this small group of subjects, differed by diagnostic stage. A delayed 80- to 100-min scan provided a reasonable substitute for a dynamic 0- to 100-min acquisition for cortical regions although other windows (e.g., 75-105 min) may be useful to evaluate.

Original languageEnglish (US)
Pages (from-to)1535-1542
Number of pages8
JournalJournal of Nuclear Medicine
Volume57
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Cognition
Alzheimer Disease
Injections
Putamen
Cerebellum
Binding Sites
Cognitive Dysfunction

Keywords

  • F-AV-1451 (T807)
  • Kinetics
  • Kinetics
  • Neurology
  • PET
  • PET
  • Radiotracer tissue
  • Tau
  • Tracer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer disease. / Shcherbinin, Sergey; Schwarz, Adam J.; Joshi, Abhinay; Navitsky, Michael; Flitter, Matthew; Shankle, William R.; Devous, Michael D.; Mintun, Mark A.

In: Journal of Nuclear Medicine, Vol. 57, No. 10, 01.10.2016, p. 1535-1542.

Research output: Contribution to journalArticle

Shcherbinin, S, Schwarz, AJ, Joshi, A, Navitsky, M, Flitter, M, Shankle, WR, Devous, MD & Mintun, MA 2016, 'Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer disease', Journal of Nuclear Medicine, vol. 57, no. 10, pp. 1535-1542. https://doi.org/10.2967/jnumed.115.170027
Shcherbinin, Sergey ; Schwarz, Adam J. ; Joshi, Abhinay ; Navitsky, Michael ; Flitter, Matthew ; Shankle, William R. ; Devous, Michael D. ; Mintun, Mark A. / Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer disease. In: Journal of Nuclear Medicine. 2016 ; Vol. 57, No. 10. pp. 1535-1542.
@article{6717be8e28da4652b30578db86bb9ba9,
title = "Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer disease",
abstract = "We report kinetic modeling results of dynamic acquisition data from 0 to 100 min after injection with the tau PET tracer 18F-AV-1451 in 19 subjects. Methods: Subjects were clinically diagnosed as 4 young cognitively normal, 5 old cognitively normal, 5 mild cognitive impairment, and 5 Alzheimer disease (AD). Kinetic modeling was performed using Logan graphical analysis with the cerebellum crus as a reference region. Voxelwise binding potential (BP) and SUV ratio (SUVR80-100) images were compared. Results: In AD subjects, slower and spatially nonuniform clearance from cortical regions was observed as compared with the controls, which led to focal uptake and elevated retention in the imaging data from 80 to 100 min after injection. BP from the dynamic data from 0 to 100 min correlated strongly (R2 > 0.86) with corresponding regional SUVR80-100-1 values. In the putamen, the observed kinetics (positive SUVR1-5-1 at the tracer delivery stage and plateauing time - SUVR curves for all diagnostic categories) may suggest either additional off-target binding or a second binding site with different kinetics. Conclusion: The kinetics of the 18F-AV-1451 tracer in cortical areas, as examined in this small group of subjects, differed by diagnostic stage. A delayed 80- to 100-min scan provided a reasonable substitute for a dynamic 0- to 100-min acquisition for cortical regions although other windows (e.g., 75-105 min) may be useful to evaluate.",
keywords = "F-AV-1451 (T807), Kinetics, Kinetics, Neurology, PET, PET, Radiotracer tissue, Tau, Tracer",
author = "Sergey Shcherbinin and Schwarz, {Adam J.} and Abhinay Joshi and Michael Navitsky and Matthew Flitter and Shankle, {William R.} and Devous, {Michael D.} and Mintun, {Mark A.}",
year = "2016",
month = "10",
day = "1",
doi = "10.2967/jnumed.115.170027",
language = "English (US)",
volume = "57",
pages = "1535--1542",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "10",

}

TY - JOUR

T1 - Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer disease

AU - Shcherbinin, Sergey

AU - Schwarz, Adam J.

AU - Joshi, Abhinay

AU - Navitsky, Michael

AU - Flitter, Matthew

AU - Shankle, William R.

AU - Devous, Michael D.

AU - Mintun, Mark A.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - We report kinetic modeling results of dynamic acquisition data from 0 to 100 min after injection with the tau PET tracer 18F-AV-1451 in 19 subjects. Methods: Subjects were clinically diagnosed as 4 young cognitively normal, 5 old cognitively normal, 5 mild cognitive impairment, and 5 Alzheimer disease (AD). Kinetic modeling was performed using Logan graphical analysis with the cerebellum crus as a reference region. Voxelwise binding potential (BP) and SUV ratio (SUVR80-100) images were compared. Results: In AD subjects, slower and spatially nonuniform clearance from cortical regions was observed as compared with the controls, which led to focal uptake and elevated retention in the imaging data from 80 to 100 min after injection. BP from the dynamic data from 0 to 100 min correlated strongly (R2 > 0.86) with corresponding regional SUVR80-100-1 values. In the putamen, the observed kinetics (positive SUVR1-5-1 at the tracer delivery stage and plateauing time - SUVR curves for all diagnostic categories) may suggest either additional off-target binding or a second binding site with different kinetics. Conclusion: The kinetics of the 18F-AV-1451 tracer in cortical areas, as examined in this small group of subjects, differed by diagnostic stage. A delayed 80- to 100-min scan provided a reasonable substitute for a dynamic 0- to 100-min acquisition for cortical regions although other windows (e.g., 75-105 min) may be useful to evaluate.

AB - We report kinetic modeling results of dynamic acquisition data from 0 to 100 min after injection with the tau PET tracer 18F-AV-1451 in 19 subjects. Methods: Subjects were clinically diagnosed as 4 young cognitively normal, 5 old cognitively normal, 5 mild cognitive impairment, and 5 Alzheimer disease (AD). Kinetic modeling was performed using Logan graphical analysis with the cerebellum crus as a reference region. Voxelwise binding potential (BP) and SUV ratio (SUVR80-100) images were compared. Results: In AD subjects, slower and spatially nonuniform clearance from cortical regions was observed as compared with the controls, which led to focal uptake and elevated retention in the imaging data from 80 to 100 min after injection. BP from the dynamic data from 0 to 100 min correlated strongly (R2 > 0.86) with corresponding regional SUVR80-100-1 values. In the putamen, the observed kinetics (positive SUVR1-5-1 at the tracer delivery stage and plateauing time - SUVR curves for all diagnostic categories) may suggest either additional off-target binding or a second binding site with different kinetics. Conclusion: The kinetics of the 18F-AV-1451 tracer in cortical areas, as examined in this small group of subjects, differed by diagnostic stage. A delayed 80- to 100-min scan provided a reasonable substitute for a dynamic 0- to 100-min acquisition for cortical regions although other windows (e.g., 75-105 min) may be useful to evaluate.

KW - F-AV-1451 (T807)

KW - Kinetics

KW - Kinetics

KW - Neurology

KW - PET

KW - PET

KW - Radiotracer tissue

KW - Tau

KW - Tracer

UR - http://www.scopus.com/inward/record.url?scp=84991386848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991386848&partnerID=8YFLogxK

U2 - 10.2967/jnumed.115.170027

DO - 10.2967/jnumed.115.170027

M3 - Article

C2 - 27151986

AN - SCOPUS:84991386848

VL - 57

SP - 1535

EP - 1542

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 10

ER -